menu search

Travere therapeutics to present abstracts at the society for the study of inborn errors of metabolism annual symposium 2023

SAN DIEGO, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company will present clinical data fro...

August 24, 2023, 4:30 pm

Retailer results, existing-home sales data leave equities mixed

US benchmark equity indexes closed mixed Tuesday as investors evaluated the latest batch of retailer ea...

August 22, 2023, 9:16 pm

Walgreens vs. cvs: i call a tie now based on a peter lynch evaluation

This is an update to an earlier article I published on Walgreens and CVS back in April 2023. That article eval...

August 16, 2023, 12:51 pm

Psf: historic underperformance and declining nav are concerns

Inflation rates in the U.S. and other G20 nations have been at their highest levels since the late 1970s, causing financial strain for many individual...

August 10, 2023, 12:35 pm

Rbnz stress test results for insurers show there is no stress

RBNZ Deputy Governor Christian Hawkesby announced the completion of New Zealand's first stress test for life insurers. The test ...

August 7, 2023, 10:54 pm

Tesla: my 13 point countdown

Tesla, Inc. stock has significantly outperformed this year, although the last month has jolted the stock a little. All stock-fundamental factors I ...

August 7, 2023, 9:42 am

Muc: when discounts aren't enough (rating downgrade)

The BlackRock MuniHoldings California Quality Fund is evaluated as an investment option at its current ...

July 28, 2023, 9:22 am

Usd/cad forecast: investors weigh fed’s september tightening

Investors evaluated potential further tightening by the Federal Reserve in September. The Fed increased...

July 27, 2023, 8:23 am

Bui: reasonable buy at this level (rating upgrade)

The BlackRock Utility & Infrastructure Trust (BUI) is evaluated as an investment option, with the fund'...

July 25, 2023, 1:16 pm

Narrowing down high-quality dividend growth: elevance health is elemental

A watchlist of high-quality dividend growth companies is evaluated to identify potential bargains in th...

July 24, 2023, 5:16 am

Astria (atxs) rises 5% on fast track tag for angioedema drug

Astria (ATXS) gets FDA's fast track tag for its lead product candidate, STAR-0215, which is currently being ev...

July 21, 2023, 9:12 am

Bank earnings, consumer sentiment report leave equities mixed

US benchmark equity indexes were struggling for direction before Friday’s close as investors evaluated...

July 14, 2023, 8:15 pm

Tan: best renewable electricity etf

We conducted a comprehensive analysis and comparison of three ETFs (TAN, QCLN, and ICLN) to determine the best Renewable ETF. The assessment examined ...

July 12, 2023, 12:57 am

Nanobiotix surges on commercialization deal with j&j's janssen for cancer therapeutic

French biotechnology company Nanobiotix has entered into an agreement with J&J's wholly-owned medical research and pharmaceutical arm Janssen to licen...

July 10, 2023, 1:11 pm

Nanobiotix's stock soars after entering licensing, development deal with j&j's janssen pharmaceutica

Shares of Nanobiotix SA NBTX, +1.57% shot up 52.1% toward a 17-month high in premarket trading Monday, after the France-based biotechnology company an...

July 10, 2023, 6:14 am

Spero therapeutics: the multi-asset pipeline could outpace the tebipenem hbr deal with gsk

Spero is eligible to receive up to $525 million in development and sales milestone payments as well as royalties on net product sales under the agreem...

July 5, 2023, 3:06 pm

Aadi bioscience: high risk/high reward

Today, we take our first look at a small cap oncology name called Aadi Bioscience, Inc. The firm's main asset is a product called FYARRO which is appr...

June 29, 2023, 6:10 pm

Atossa therapeutics hits 30% enrollment for (z)-endoxifen arm of ongoing i-spy 2 clinical trial

Atossa Therapeutics Inc (NASDAQ:ATOS), which is developing medicines aimed at oncology and breast cancer, revealed that six patients have been dosed w...

June 28, 2023, 11:01 am

Theriva biologics jumps on us fda approval for pancreatic cancer treatment

Theriva Biologics Inc saw its shares surge over 70% higher in after-hours US trading following news that its lead clinical candidate, VCN-01, has bee...

June 28, 2023, 8:51 am

Russian coup turmoil: oil and european stocks steady

Crude oil and European stocks showed resilience in the face of Russian coup, as investors analyzed the potential consequences and ...

June 26, 2023, 3:41 pm


Search within

Pages Search Results: